I get a single digit PE on FY2022 numbers on fairly conservative assumptions. Zoleo is a great product in a growing market that has excellent economics. There’s also all the other products with new updates for Iridium coming.
The two year play here is Iridium to buy out BCC. Makes strategic sense for the group. The key will be getting some scale and size before then so that the premium is worth it.
I get a single digit PE on FY2022 numbers on fairly conservative...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.23M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42000 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 55000 | 1 |
View Market Depth
| Last trade - 16.21pm 01/08/2025 (20 minute delay) ? |
| BCC (ASX) Chart |
Day chart unavailable